Literature DB >> 17976011

Characterization and comparative 3D modeling of CmPI-II, a novel 'non-classical' Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca).

Yamile González1, Tirso Pons, Jeovanis Gil, Vladimir Besada, Maday Alonso-del-Rivero, Aparecida S Tanaka, Mariana S Araujo, María A Chávez.   

Abstract

The complete amino acid sequence obtained by electrospray ionization tandem mass spectrometry of the proteinase inhibitor CmPI-II isolated from Cenchritis muricatus is described. CmPI-II is a 5480-Da protein with three disulfide bridges that inhibits human neutrophil elastase (HNE) (K(i) 2.6+/-0.2 nM), trypsin (K(i) 1.1+/-0.9 nM), and other serine proteinases such as subtilisin A (K(i) 30.8+/-1.2 nM) and pancreatic elastase (K(i) 145.0+/-4.4 nM); chymotrypsin, pancreatic and plasma kallikreins, thrombin and papain are not inhibited. CmPI-II shares homology with the Kazal-type domain and may define a new group of 'non-classical' Kazal inhibitors according to its Cys(I)-Cys(V) disulfide bridge position. The 3D model of CmPI-II exhibits similar secondary structure characteristics to Kazal-type inhibitors and concurs with circular dichroism experiments. A 3D model of the CmPI-II/HNE complex provides a structural framework for the interpretation of its experimentally determined K(i) value. The model shows both similar and different contacts at the primary binding sites in comparison with the structure of turkey ovomucoid third domain (OMTKY3)/HNE used as template. Additional contacts calculated at the protease-inhibitor interface could also contribute to the association energy of the complex. This inhibitor represents an exception in terms of specificity owing to its ability to strongly inhibit elastases and trypsin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976011     DOI: 10.1515/BC.2007.129

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  6 in total

1.  Crystal structure of novel metallocarboxypeptidase inhibitor from marine mollusk Nerita versicolor in complex with human carboxypeptidase A4.

Authors:  Giovanni Covaleda; Maday Alonso del Rivero; María A Chávez; Francesc X Avilés; David Reverter
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

2.  Tri-domain bifunctional inhibitor of metallocarboxypeptidases A and serine proteases isolated from marine annelid Sabellastarte magnifica.

Authors:  Maday Alonso-del-Rivero; Sebastian A Trejo; Mey L Reytor; Monica Rodriguez-de-la-Vega; Julieta Delfin; Joaquin Diaz; Yamile González-González; Francesc Canals; Maria Angeles Chavez; Francesc X Aviles
Journal:  J Biol Chem       Date:  2012-03-12       Impact factor: 5.157

3.  Three-dimensional Structure of a Kunitz-type Inhibitor in Complex with an Elastase-like Enzyme.

Authors:  Rossana García-Fernández; Markus Perbandt; Dirk Rehders; Patrick Ziegelmüller; Nicolas Piganeau; Ulrich Hahn; Christian Betzel; María de Los Ángeles Chávez; Lars Redecke
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

4.  Crystal structure of Aedes aegypti trypsin inhibitor in complex with μ-plasmin reveals role for scaffold stability in Kazal-type serine protease inhibitor.

Authors:  Varsha Ashok Walvekar; Karthik Ramesh; Chacko Jobichen; Muthu Kannan; J Sivaraman; R Manjunatha Kini; Yu Keung Mok
Journal:  Protein Sci       Date:  2021-11-29       Impact factor: 6.725

5.  Polar Desolvation and Position 226 of Pancreatic and Neutrophil Elastases Are Crucial to their Affinity for the Kunitz-Type Inhibitors ShPI-1 and ShPI-1/K13L.

Authors:  Jorge Enrique Hernández González; Rossana García-Fernández; Pedro Alberto Valiente
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

6.  Molecular Cloning and Functional Studies of Two Kazal-Type Serine Protease Inhibitors Specifically Expressed by Nasonia vitripennis Venom Apparatus.

Authors:  Cen Qian; Qi Fang; Lei Wang; Gong-Yin Ye
Journal:  Toxins (Basel)       Date:  2015-08-04       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.